Memory T cell
This article needs attention from an expert in Molecular and Cell Biology. The specific problem is: difficult to follow, too technical.November 2017)(
Memory T cells are a subset of infection- and cancer-fighting T cells (also known as a T lymphocyte) that have previously encountered and responded to their cognate antigen; thus, the term antigen-experienced T cell is often applied. In comparison to naive T cells, which are T cells that have not been exposed to antigens yet, memory T cells can reproduce to mount a faster and stronger immune response. Such T cells can recognize foreign invaders, such as bacteria or viruses, as well as cancer cells. A prior infection, an encounter with cancer, or a previous vaccination has made them "experienced". This behaviour is utilized in T lymphocyte proliferation assays, which can reveal exposure to specific antigens.
Currently, the field is still debating about the lineage relationship between effector and memory T cells. Two competing models exist. One is called the "On-Off-On" model. When naive T cells are activated by T cell receptor (TCR) binding to antigen and its downstream signaling pathway, they actively proliferate and form a large clone of effector cells. Effector cells undergo active cytokine secretion and other effector activities. After antigen clearance, some of these effector cells form memory T cells, either in a randomly determined manner or are selected based on their superior specificity. These cells would reverse from the active effector role to a state more similar to naive T cells and would be "turned on" again upon the next antigen exposure. This model predicts that effector T cells can transit into memory T cells and survive, retaining the ability to proliferate. It also predicts that certain gene expression profile would follow the on-off-on pattern during naive, effector and memory stages. Evidence supporting this model includes the finding of genes related to survival and homing that follow the on-off-on expression pattern, including interleukin-7 receptor alpha (IL-7Rα), Bcl-2, CD26L and others.
The other model is the developmental differentiation model. This model argues that effector cells produced by the highly activated naive T cells would all undergo apoptosis after antigen clearance. Memory T cells are instead produced by naive T cells that are activated, but never entered with full-strength into the effector stage. The progeny of memory T cells are not fully activated because they are not as specific to the antigen as the expanding effector T cells. Studies looking at cell division history found that the length of telomere and activity of telomerase were reduced in effector T cells comparing to memory T cells, which suggests that memory T cells did not undergo as much cell division as effector T cells, which is inconsistent with the "On-Off-On" model. Repeated or chronic antigenic stimulation of T cells, like HIV infection, would induce elevated effector functions but reduce memory. It was also found that massively proliferated T cells are more likely to generate short-lived effector cells, while minimally proliferated T cells would form more long-lived cells.
Due to the motility of memory T cells and lack of distinct cell surface markers, the understanding of memory T cell lineage is still murky. Future research on the topic is needed to clarifying the lineage debate.
Part of what makes memory T cells being able to mount a faster and stronger immune response are epigenetic modifications on their genome that make them different from native T cells. Epigenetic modifications are modifications on the DNA or chromatin proteins without changing the DNA sequence itself. These events, mainly DNA methylation or histone modifications, are able to change the accessibility of certain chromatin regions and affect the function of regulatory elements on the genome, which changes the gene expression profiles of these T cells. For example, in CD4+ memory T cells, positive histone modifications mark key cytokine genes that are up-regulated during secondary immune response, including IFNG, IL4, and IL17A. Some of these modifications persisted after antigen clearance, establishing an epigenetic memory that allows a faster activation upon re-encounter with the antigen. For CD8+ memory T cells, certain effector genes, such as IFNG, would not be expressed but they are transcriptionally-poised for fast expression upon activation. It is also worth noticing that the enhancement of expression for certain genes also depends on the strength of the initial TCR signaling for the progeny of memory T cells, which is correlated to the regulatory element activation that directly changes gene expression level.
Historically, memory T cells were thought to belong to either the effector or central memory subtypes, each with their own distinguishing set of cell surface markers (see below). Subsequently, numerous additional populations of memory T cells were discovered including tissue-resident memory T (TRM) cells, stem memory TSCM cells, and virtual memory T cells. The single unifying theme for all memory T cell subtypes is that they are long-lived and can quickly expand to large numbers of effector T cells upon re-exposure to their cognate antigen. By this mechanism they provide the immune system with "memory" against previously encountered pathogens. Memory T cells may be either CD4+ or CD8+ and usually express CD45RO and at the same time lack CD45RA.
Memory T cell subtypes:
- Central memory T cells (TCM cells) express CD45RO, C-C chemokine receptor type 7 (CCR7), and L-selectin (CD62L). Central memory T cells also have intermediate to high expression of CD44. This memory subpopulation is commonly found in the lymph nodes and in the peripheral circulation.
- Effector memory T cells (TEM cells) express CD45RO but lack expression of CCR7 and L-selectin. They also have intermediate to high expression of CD44. These memory T cells lack lymph node-homing receptors and are thus found in the peripheral circulation and tissues. TEMRA stands for terminally differentiated effector memory cells re-expressing CD45RA, which is a marker usually found on naive T cells.
- Tissue resident memory T cells (TRM) occupy tissues (skin, lung, gastrointestinal tract, etc.) without recirculating. Some cell surface markers that have been associated with TRM are CD69 and integrin αeβ7 (CD103). However, it is worth noticing that TRM cells found in different tissues express different sets of cell surface markers. While CD103+ TRM cells are found to be restrictedly localized to epithelial and neuronal tissues, TRM cells localized in salivary glands, pancreas and female reproductive tracts in mice express neither CD69 or CD103. TRM cells are thought to play a major role in protective immunity against pathogens. Studies have also suggested a dual role for TRM cells in protection and regulation. Compared to TEM cells, TRM cells secrete higher levels of protective-immunity-related cytokines and express lower levels of the proliferation marker Ki67. It was proposed that these characteristics may help with long-term maintenance of TRM cells, as well as keeping a balance between quick response to antigen invasion and avoidance of unnecessary tissue damage. Dysfunctional TRM cells have been implicated in autoimmune diseases, such as psoriasis, rheumatoid arthritis, inflammatory bowel disease. Specific to TRM lymphocytes are genes involved in lipid metabolism, being highly active, roughly 20- to 30-fold more active than in other types of T-cells.
- Virtual memory T cells (TVM) differ from the other memory subsets in that they do not originate following a strong clonal expansion event. Thus, although this population as a whole is abundant within the peripheral circulation, individual virtual memory T cell clones reside at relatively low frequencies. One theory is that homeostatic proliferation gives rise to this T cell population. Although CD8 virtual memory T cells were the first to be described, it is now known that CD4 virtual memory cells also exist.
There have been numerous other subpopulations of memory T cells suggested. Investigators have studied Stem memory TSCM cells. Like naive T cells, TSCM cells are CD45RO−, CCR7+, CD45RA+, CD62L+ (L-selectin), CD27+, CD28+ and IL-7Rα+, but they also express large amounts of CD95, IL-2Rβ, CXCR3, and LFA-1, and show numerous functional attributes distinctive of memory cells.
Antigen-specific memory T cells against viruses or other microbial molecules can be found in both TCM and TEM subsets. Although most information is currently based on observations in the cytotoxic T cells (CD8-positive) subset, similar populations appear to exist for both the helper T cells (CD4-positive) and the cytotoxic T cells. Primary function of memory cells is augmented immune response after reactivation of those cells by reintroduction of relevant pathogen into the body. It is important to note that this field is intensively studied and some information may not be available as of yet.
- TCM : TCM lymphocytes have several attributes in common with stem cells, the most important being the ability of self-renewal, mainly because of high level of phosphorylation on key transcription factor, STAT5. In mice, TCM proved to confer more powerful immunity against viruses, bacteria and cancer cells, compared to TEM lymphocytes in several experimental models.
- TEM : TEM and TEMRA lymphocytes are primarily active as the CD8 variants, thus being mainly responsible for cytotoxic action against pathogens.
- TRM : Because Trm are present over long periods of time in tissues, or more importantly, barrier tissues(epithelium for example), they are crucial for quick response to barrier breach and response to any relevant pathogen present. Among mechanism that are used by TRM to restrict pathogens is the secretion of granzyme B.
- TSCM : Those lymphocytes are capable of self-renewal as are the TCM lymphocytes and are also capable of generating both the TCM and TEM subpopulations. Presence of this population in humans is currently under investigation.
- TVM : As of now, the only function apparent in TVM cells is production of various cytokines, but there are speculations about their influence in subduing unwanted immunological states and their usage in treating autoimmune disorders.
Clones of memory T cells expressing a specific T cell receptor can persist for decades in our body. Since memory T cells have shorter half-lives than naive T cells do, continuous replication and replacement of old cells is likely involved in the maintenance process.<ref name="Farber_2014"> Currently, the mechanism behind memory T cell maintenance is not fully understood. Activation through T cell receptor may play a role. It is found that memory T cells can sometimes react to novel antigens, potentially caused by intrinsic diversity and breadth of the T cell receptor binding targets. These T cells could cross-react to environmental or resident antigens in our bodies (like bacteria in our gut) and proliferated. These events would help maintain the memory T cell population. The cross-reactivity mechanism may be important for memory T cells at the mucosal tissues since these sites have higher antigen density. For those resident in blood, bone marrow, lymphoid tissues and spleen, homeostatic cytokines (including IL-17 and IL-15) or major histocompatibility complex II (MHCII) signaling may be more important.
Memory T cells undergo different changes and play different roles in different life stages for humans. At birth and early childhood, T cells in the peripheral blood are mainly naive T cells. Through frequent antigen exposure, the population of memory T cells accumulates. This is the memory generation stage, which lasts from birth to about 20-25 years old, when our immune system encounter the greatest number of new antigen. During the memory homeostasis stage that comes next, the number of memory T cells plateaus and is stabilized by homeostatic maintenance. At this stage, the immune response shifts more towards maintaining homeostasis since few new antigens are encountered. Tumor surveillance also becomes important at this stage. At later stages of life, at about 65-70 years of age, immunosenescence stage comes, in which stage immune dysregulation, decline in T cell functionality and increased susceptibility to pathogens are observed.
- Restifo NP, Gattinoni L (October 2013). "Lineage relationship of effector and memory T cells". Current Opinion in Immunology. Special section: Systems biology and bioinformatics / Immunogenetics and transplantation. 25 (5): 556–63. doi:10.1016/j.coi.2013.09.003. PMC 3858177. PMID 24148236.
- Henning AN, Roychoudhuri R, Restifo NP (May 2018). "+ T cell differentiation". Nature Reviews. Immunology. 18 (5): 340–356. doi:10.1038/nri.2017.146. PMC 6327307. PMID 29379213.
- Youngblood B, Hale JS, Ahmed R (July 2013). "T-cell memory differentiation: insights from transcriptional signatures and epigenetics". Immunology. 139 (3): 277–84. doi:10.1111/imm.12074. PMC 3701173. PMID 23347146.
- Schmidl C, Delacher M, Huehn J, Feuerer M (September 2018). "Epigenetic mechanisms regulating T-cell responses". The Journal of Allergy and Clinical Immunology. 142 (3): 728–743. doi:10.1016/j.jaci.2018.07.014. PMID 30195378.
- Sallusto F, Lenig D, Förster R, Lipp M, Lanzavecchia A (October 1999). "Two subsets of memory T lymphocytes with distinct homing potentials and effector functions". Nature. 401 (6754): 708–12. Bibcode:1999Natur.401..708S. doi:10.1038/44385. PMID 10537110.
- Akbar AN, Terry L, Timms A, Beverley PC, Janossy G (April 1988). "Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells". Journal of Immunology. 140 (7): 2171–8. PMID 2965180.
- Willinger T, Freeman T, Hasegawa H, McMichael AJ, Callan MF (November 2005). "Molecular signatures distinguish human central memory from effector memory CD8 T cell subsets". Journal of Immunology. 175 (9): 5895–903. doi:10.4049/jimmunol.175.9.5895. PMID 16237082.
- Koch S, Larbi A, Derhovanessian E, Ozcelik D, Naumova E, Pawelec G (July 2008). "Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people". Immunity & Ageing. 5 (6): 6. doi:10.1186/1742-4933-5-6. PMC 2515281. PMID 18657274.
- Mueller SN, Mackay LK (February 2016). "Tissue-resident memory T cells: local specialists in immune defence". Nature Reviews. Immunology. 16 (2): 79–89. doi:10.1038/nri.2015.3. PMID 26688350.
- Steinert EM, Schenkel JM, Fraser KA, Beura LK, Manlove LS, Igyártó BZ, et al. (May 2015). "Quantifying Memory CD8 T Cells Reveals Regionalization of Immunosurveillance". Cell. 161 (4): 737–49. doi:10.1016/j.cell.2015.03.031. PMC 4426972. PMID 25957682.
- Shin H, Iwasaki A (September 2013). "Tissue-resident memory T cells". Immunological Reviews. 255 (1): 165–81. doi:10.1111/imr.12087. PMC 3748618. PMID 23947354.
- "Study highlights possible Achilles' heel in key immune memory cells".
- Kumar BV, Connors TJ, Farber DL (February 2018). "Human T Cell Development, Localization, and Function throughout Life". Immunity. 48 (2): 202–213. doi:10.1016/j.immuni.2018.01.007. PMC 5826622. PMID 29466753.
- Lee YJ, Jameson SC, Hogquist KA (February 2011). "Alternative memory in the CD8 T cell lineage". Trends in Immunology. 32 (2): 50–6. doi:10.1016/j.it.2010.12.004. PMC 3039080. PMID 21288770.
- Marusina AI, Ono Y, Merleev AA, Shimoda M, Ogawa H, Wang EA, et al. (February 2017). "+ virtual memory: Antigen-inexperienced T cells reside in the naïve, regulatory, and memory T cell compartments at similar frequencies, implications for autoimmunity". Journal of Autoimmunity. 77: 76–88. doi:10.1016/j.jaut.2016.11.001. PMC 6066671. PMID 27894837.
- Gattinoni L, Lugli E, Ji Y, Pos Z, Paulos CM, Quigley MF, et al. (September 2011). "A human memory T cell subset with stem cell-like properties". Nature Medicine. 17 (10): 1290–7. doi:10.1038/nm.2446. PMC 3192229. PMID 21926977.
- Wherry EJ, Teichgräber V, Becker TC, Masopust D, Kaech SM, Antia R, et al. (March 2003). "Lineage relationship and protective immunity of memory CD8 T cell subsets". Nature Immunology. 4 (3): 225–34. doi:10.1038/ni889. PMID 12563257.
- Klebanoff CA, Gattinoni L, Torabi-Parizi P, Kerstann K, Cardones AR, Finkelstein SE, et al. (July 2005). "Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells". Proceedings of the National Academy of Sciences of the United States of America. 102 (27): 9571–6. Bibcode:2005PNAS..102.9571K. doi:10.1073/pnas.0503726102. PMC 1172264. PMID 15980149.
- Farber DL, Yudanin NA, Restifo NP (January 2014). "Human memory T cells: generation, compartmentalization and homeostasis". Nature Reviews. Immunology. 14 (1): 24–35. doi:10.1038/nri3567. PMC 4032067. PMID 24336101.
- Gebhardt T, Wakim LM, Eidsmo L, Reading PC, Heath WR, Carbone FR (May 2009). "Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus". Nature Immunology. 10 (5): 524–30. doi:10.1038/ni.1718. PMID 19305395.
- White JT, Cross EW, Kedl RM (June 2017). "+ T cells: where they come from and why we need them". Nature Reviews. Immunology. 17 (6): 391–400. doi:10.1038/nri.2017.34. PMC 5569888. PMID 28480897.
- Lee JY, Hamilton SE, Akue AD, Hogquist KA, Jameson SC (August 2013). "Virtual memory CD8 T cells display unique functional properties". Proceedings of the National Academy of Sciences of the United States of America. 110 (33): 13498–503. Bibcode:2013PNAS..11013498L. doi:10.1073/pnas.1307572110. PMC 3746847. PMID 23898211.
- Drobek A, Moudra A, Mueller D, Huranova M, Horkova V, Pribikova M, et al. (July 2018). "Strong homeostatic TCR signals induce formation of self-tolerant virtual memory CD8 T cells". The EMBO Journal. 37 (14). doi:10.15252/embj.201798518. PMC 6043851. PMID 29752423.